NeoGenomics: George Cardoza, Steven Brodie, David Sholehvar
George Cardoza, president and chief operating officer of laboratory operations for NeoGenomics is retiring from both positions, effective March 31. Steven Brodie, currently senior vice president of laboratory operations at NeoGenomcs has been appointed interim president of lab operations at the firm.
Additionally, David Sholehvar was appointed president of the clinical services division of the company, effective March 14. Before joining NeoGenomics, he was CEO of Dynex Technologies. Before that, he was VP of Quest Diagnostics' largest sales region, as well as GM of infectious disease and immunology. He also was VP for the Americas and Europe, Middle East, and Africa for Johnson & Johnson Ortho Clinical Diagnostics.